Specializing in the treatment of
children with endocrine disorders
diabetes, Type 2 diabetes, Hypothyroidism, Hyperthyroidism, Graves Disease, Short Stature, Growth Hormone Deficiency,
Precocious (early) puberty, Delayed Puberty, Adrenal Insufficiency, Obesity,
Rickets, Osteoporosis, low Vitamin D levels, Prader-Willi
Syndrome, Short stature due to small for gestational age,
Hypercholesterolemia and Hyperlipidemia (High cholesterol)
The Division of Pediatric
located at the Saint Barnabas
375 Mt Pleasant Ave Suite 105,
West Orange, NJ 07052.
Our office is readily accessible from
many surrounding communities in Essex, Passaic, Morris, Union, Bergen, Hudson,
Middlesex, and Somerset counties.
Awards, Honors & Recognition
Publications / Poster Presentations
Central Precocious Puberty Associated with a
Dax-1 (NROB1) Mutation Causing Adrenal Hypoplasia Congenita. Brenner D,
Elbashir A. Poster Presentation, Endocrine Society Annual Meeting, May 5-8,
2015, San Diego, CA
Optimal Hyperlipidemia Monitoring in Children
and Adolescents with Type 1 Diabetes Mellitus. Allen HA, Brenner D, Reiter
O. Poster Presentation, Lawson Wilkins Pediatric Endocrine Society Meeting,
Honolulu, Hawaii, May 2008
Prospective Detection Of Hyperglycemia In
Critically Ill Children Using Continuous Glucose Monitoring. Allen HF, Rake
A, Roy M, Brenner D, McKiernan CA. Pediatric Critical Care Medicine.
9(2):153-158, March 2008.
Association Between Phone Contact And
Inter-visit Glycemic Control In Type 1 Diabetic Children. Brenner D, Ben-Chaim
A, Allen HF, Reiter EO. Presented at American Diabetes Association
Scientific Session, Chicago, IL, June 22-24, 2007.
Does Increased BMI Impair Predicted Adult
Height in Female Patients Treated with Depot GnRH for Precocious Puberty?
Morneault E, Allen HA, Brenner D, Poster presentation, Lawson Wilkins
Pediatric Endocrine Society Meeting, Toronto, Canada, May 7, 2007.
Weight Percentiles in Obese Hyperinsulinemic and Obese Hyperandrogenemic
Adolescent Females Compared to Obese Controls. Brenner D, Allen HF, Reiter
EO. Poster presentation, Endocrine Society Annual Meeting, Boston, MA, June
of Body Composition in Girls treated for Precocious Puberty with GnRH
Agonists. Brenner D, Allen HF, Reiter EO. Poster presentation, ESPE-LWPES
joint meeting, Lyon, France, September 2005.
randomized controlled trial of OCP vs OCP with metformin in adolescents with
PCOS. Allen HF, Brenner D, Reiter, EO. Poster presentation, ESPE-LWPES joint
meeting, Lyon, France, September 2005.
Attitudes about Hypoglycemia in Type I Diabetics. Brenner D, Carey DE, Frank
GR, Kreitzer P. Poster presentation, Endocrine Society Annual Meeting, San
Diego, CA, June 2005.
Acquired Abnormalities Of The
Hypothalamic-Pituitary Axis Leading To Growth Impairment. Brenner DJ, Reiter
EO. Chapter, in “Clinical Pediatric Endocrinology” 5th Edition,
Blackwell Publishing, 2005 Edited by Charles Brook.
Immunoregulatory T Cell Population In New-onset Type I Diabetic Children
Compared To That Of Normal Children. Brenner DJ, McCloskey TW, Pahwa S,
Speiser PW Poster presentation, Endocrine Society Annual Meeting, New
Orleans, LA, June 2004.
Adrenal Hyperplasia due to 21-hydroxylase Deficiency. Speiser PW, Brenner
DJ. Endocrinologist. 13(4):334-340, July/August 2003.
Computerization of a Hospital-Based Pediatric Endocrinology Practice.
Brenner DJ, Carey DE, Frank GR, Fort P, Kreitzer PK, Speiser PW Poster
presentation, Lawson Wilkins Pediatric Endocrine Society Meeting, Baltimore,
MD, May 2002.
Puberty in Rubinstein-Taybi Syndrome. Brenner DJ, Speiser PW. Poster
presentation, Endocrine Society Annual Meeting, Denver, CO, June, 2001.
Profiles of obese children presenting for
metabolic evaluation. Anavian J, Brenner DJ, Fort P,
Speiser PW. Journal of Pediatric Endocrinology and Metabolism 2001
Principal investigator, Macrogenics Protégé,
Protégé Extension, Protégé Subcutaneous, and Protégé Encore studies, 2008 -
Principal investigator, Pfizer
“Individualized, Target-Driven Treatment Of Children With Idiopathic Short
Stature”, 2008 - 2012
Principal investigator , Insmed, “Research
Study Using Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human
Insulin-Like Growth Factor Binding Protein-3 for Children With Noonan
Principal investigator, Tercica, IGF-1 and
growth hormone combined treatment study, 2008 - 2012
Principal investigator, Tercica, “Recombinant
Human Insulin-like Growth Factor-1 (rhIGF-1) treatment of pre-pubertal
children with growth failure associated with primary IGF-1 Deficiency, An
Open Label Multi Center, Extension Study”, 2008 - 2012
Principal Investigator, A Multicenter,
Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy
and Safety of Saxagliptin (BMS-477118) in Combination with Metformin IR or
Metformin XR in Pediatric Patients with Type 2 Diabetes who have Inadequate
Glycemic Control on Metformin Alone; Bristol- Myers Squibb, 2012 - 2013
Principal Investigator, Colesevelam oral
suspension as monotherapy or add-on to metformin therapy in pediatric
subjects with type 2 diabetes mellitus; Daiichi Sankyo Pharma Solutions,
2012 - present
Principal Investigator, An
open-label, non-comparative, multicenter study on the efficacy, safety, and
pharmacokinetics of triptorelin pamoate (embonate) 22.5 mg 6-month
formulation in patients suffering from central (gonadotropin-dependent)
precocious puberty; Debio Pharm Group, 2012 - 2014
Principal Investigator, Natural history study
of the development of type 1 diabetes; Trial Net , 2012 – present
Sub investigator, Novo-Nordisk, “Norditropin
National Registry protocol”, 2010 - present
Sub investigator, Pfizer, “KIGS Registry for
Growth Hormone Therapy”, 2010 - 2012
Sub investigator, Eli Lilly, “GENESIS”
registry , 2012 - present
Sub investigator, Genentech “A Postmarketing
Surveillance Program for Nutropin, Nutropin AQ, and Protropin”, 2010
Principal Investigator, Versartis, VRS-317
(long-acting hGH) in Children with Growth Hormone Deficiency, 2013
Principal Investigator, Novo Nordisk,
Efficacy and safety of liraglutide in combination with metformin versus
metformin monotherapy on glycaemic control in children and adolescents with
type 2 diabetes, 2012 - present
“An interesting case of short staure” Saint
Barnabas Medical Center, Livingston, NJ, Feb 2015<
“What is the diagnosis? Severe Hypothyroidism.”
Newark Beth Israel Medical Center, Newark, NJ, November 2013
“Treatment of Hyperlipidemia in Pediatrics”
Saint Barnabas Medical Center Pediatric Nephrology Symposium, October 2013
“Cushing’s Disease in Pediatrics” Newark Beth
Israel Medical Center, Newark, NJ, February 2013
“Update on the Treatment of Diabetes", Grand
Rounds, Trinitas Medical Center, Elizabeth, New Jersey, July 2012
“Obesity” Saint Barnabas CME program, April
“Endocrine issues in neonatology” Newark Beth
Israel Medical Center, Newark, NJ, November 2011
“An interesting case of Short Stature” JFK
Medical Center, Edison, NJ, July 2011
"Update on the Treatment of Diabetes", Grand
Rounds, Newark Beth Israel Medical Center, Newark, New Jersey, March 2010
"Advances in the Treatment of Diabetes", Grand
Rounds, Saint Barnabas Medical Center, Livingston, New Jersey, April 2009
"Endocrine Emergencies," Grand Rounds, Newark
Beth Israel Medical Center, Newark, New Jersey, December 2008
Complications of Obesity” JFK Medical Center, Edison, NJ, October 16, 2008
Benefits of EMR implementation” Lawson Wilkens Pediatric Endocrinology Society
Annual Meeting, Toronto, Canada, May 6, 2007.
Posterior Pituitary.” Pediatric Grand Rounds, Baystate Children’s Hospital,
Springfield, MA, August, 2006.
“Precocious Puberty.” Reproductive
Endocrinology Grand Rounds, Baystate Medical Center, Springfield, MA April
of the pediatric endocrinology practice” Hackensack University Medical Center,
Hackensack, NJ, April 7, 2005.
Small for Gestational Age Infants with Growth Hormone”, Springfield, MA, March
and Treatment of Diabetic Ketoacidosis.” Pediatric Grand Rounds, Baystate
Medical Center, August 31, 2004.
call: Pediatric Diabetes.” WGBY, Public Broadcasting Service, Springfield, MA,
March 23, 2004.
from Pediatric to Adult Endocrine Care.” Adult Endocrinology Grand Rounds,
Baystate Medical Center, December 30, 2003.